COMMUNIQUÉS West-GlobeNewswire

MAIA Biotechnology Announces $2.25 Million Private Placement
29/09/2025
CHICAGO, IL, Sept. 29, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today [...]
Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
29/09/2025
PONTE VEDRA, Fla., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the gaps in anticoagulation therapy, today [...]
Precision Optics Reports Fourth Quarter and Fiscal Year 2025 Financial Results
29/09/2025
Conference Call Scheduled for today, September 29, 2025, at 5:00pm ET Company introduces fiscal year 2026 Revenue and Adjusted EBITDA guidance Company appoints new Chief Operating Officer GARDNER, Mass., Sept. 29, 2025 [...]
Neuphoria Provides Fiscal Year-End 2025 Financial Results and Business Updates
29/09/2025
Last patient last visit (LPLV) milestone in AFFIRM-1 Phase 3 trial of BNC-210 in social anxiety disorder (SAD) achieved; topline readout anticipated in early Q4 2025 Cash runway extended through fiscal Q2 2027 [...]
Eupraxia Pharmaceuticals Announces Positive Data from Highest-Dose Cohort in the Ongoing RESOLVE Trial in Eosinophilic Esophagitis, and Plans for Expansion of EP-104GI Development Programs
29/09/2025
Clinical data was reported for the first time in patients receiving an 8 mg dose per injection (Cohort 9 of the dose escalation portion of RESOLVE), the highest dose planned in this trial. Patients in Cohort 9 [...]
Sutro Biopharma Announces Operational Restructuring Intended to Extend Cash Runway through Key Milestones
29/09/2025
– Extends cash runway into at least mid-2027 – SOUTH SAN FRANCISCO, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific [...]
INVO Fertility to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
29/09/2025
SARASOTA, Fla., Sept. 29, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare fertility company focused on expanding access to advanced treatment through the [...]
Aja Health and Wellness Inc. Provides Update on Delay in Filing Financial Statements
30/09/2025
Not for dissemination in the United States of America VANCOUVER, British Columbia, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Aja Health and Wellness Inc. ("Aja" or the "Company") (TSXV:Aja) announces that it is getting closer [...]
NANOBIOTIX Announces Updated Phase 1 Results Continuing to Support JNJ-1900 (NBTXR3) Plus Anti-PD-1 as a Potential New 1L or 2L+ Option in Anti-PD-1 Naïve or Resistant R/M-HNSCC
30/09/2025
Treatment remained well-tolerated with consistent injection feasibility in 103 heavily pre-treated patients with R/M-HNSCC naïve or resistant to anti-PD-1 63% (26/41) disease control rate (“DCR”) and 37% (15/41) [...]
Artelo Biosciences Announces Proposed Underwritten Public Offering
30/09/2025
SOLANA BEACH, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people [...]
Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases
30/09/2025
Tokyo, Japan and Cambridge and London, UK, 30 September 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) announces that it has reached a second important R&D milestone under its multi-target [...]
Vivos Inc Board Authorizes Vivos Inc to Establish a Corporate Entity in India
29/09/2025
Kennewick, WA, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) The Vivos Board granted authorization to form a wholly owned corporate subsidiary in India. Vivos Inc filed for the name of Vivos Scientific [...]
Silo Pharma Updates Strategic Agreement with Fireblocks to Secure Crypto Treasury Management
29/09/2025
Fireblocks is a globally recognized leader in the digital assets space, facilitating the secure transfer of more than $10 trillion to date SARASOTA, FL, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO [...]
Lighthouse Autism Center Announces Expansion in North Carolina with High Point Location
29/09/2025
ABA Provider Expands in North Carolina to Meet Growing Need for Autism Services MISHAWAKA, Ind., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Lighthouse Autism Center, a premier provider of center-based Applied Behavior Analysis [...]
Compass Health CEO honored with Lifetime Achievement Award from Vistage, the world’s largest CEO coaching and advisory organization
29/09/2025
The Lifetime Achievement Award recognizes a veteran member of 10+ years with a track record of bold decisions benefitting the company, community and beyond EVERETT, Wash., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Compass [...]
Glo & Spa-rkle Aesthetics and Medical Spa Launches Revolutionary Near-Painless and Precise PRP and PRF Hair Restoration Intradermal Injector Treatment
29/09/2025
Introducing Mesogun Intradermal Injection Technology for a Painless and Precise Hair Restoration Experience Lubbock, TX, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Glo & Spa-rkle Aesthetics and Medical Spa, a leading name [...]
Persephone Biosciences Co-Sponsors Event With Clean Label Project At Annual American Academy Of Pediatrics Conference
29/09/2025
Persephone’s Daily Synergistic Synbiotic Is The First Synbiotic To Receive Clean Label Project First 1,000 Days Promise Certification DENVER, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Persephone Biosciences , a pioneering [...]
Arcutis Biotherapeutics to Host Virtual Investor Day and Report Third Quarter 2025 Financial Results on October 28, 2025
29/09/2025
WESTLAKE VILLAGE, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on immuno-dermatology, today announced that it will report [...]
Consortium consisting of Nordic Capital and Permira extends offer period until 14 October 2025 and provides update on regulatory approvals in respect of the takeover offer to the shareholders of Bavarian Nordic
29/09/2025
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION COPENHAGEN, Denmark, [...]

Pages